Ocugen Inc (OCGN)
0.9009
-0.02
(-1.92%)
USD |
NASDAQ |
Nov 21, 16:00
0.9008
0.00 (0.00%)
After-Hours: 20:00
Ocugen Enterprise Value: 226.64M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 226.64M |
| November 20, 2024 | 231.77M |
| November 19, 2024 | 218.69M |
| November 18, 2024 | 229.64M |
| November 15, 2024 | 237.62M |
| November 14, 2024 | 255.51M |
| November 13, 2024 | 243.30M |
| November 12, 2024 | 261.34M |
| November 11, 2024 | 273.33M |
| November 08, 2024 | 249.12M |
| November 07, 2024 | 276.22M |
| November 06, 2024 | 250.76M |
| November 05, 2024 | 239.97M |
| November 04, 2024 | 242.12M |
| November 01, 2024 | 239.74M |
| October 31, 2024 | 228.62M |
| October 30, 2024 | 246.91M |
| October 29, 2024 | 243.80M |
| October 28, 2024 | 257.36M |
| October 25, 2024 | 232.57M |
| October 24, 2024 | 223.51M |
| October 23, 2024 | 228.36M |
| October 22, 2024 | 234.14M |
| October 21, 2024 | 236.57M |
| October 18, 2024 | 237.04M |
| Date | Value |
|---|---|
| October 17, 2024 | 234.16M |
| October 16, 2024 | 236.78M |
| October 15, 2024 | 239.10M |
| October 14, 2024 | 239.91M |
| October 11, 2024 | 250.10M |
| October 10, 2024 | 239.51M |
| October 09, 2024 | 239.62M |
| October 08, 2024 | 242.32M |
| October 07, 2024 | 252.25M |
| October 04, 2024 | 257.36M |
| October 03, 2024 | 239.22M |
| October 02, 2024 | 245.75M |
| October 01, 2024 | 239.94M |
| September 30, 2024 | 252.19M |
| September 27, 2024 | 280.78M |
| September 26, 2024 | 270.82M |
| September 25, 2024 | 282.22M |
| September 24, 2024 | 268.17M |
| September 23, 2024 | 286.53M |
| September 20, 2024 | 306.68M |
| September 19, 2024 | 315.32M |
| September 18, 2024 | 309.56M |
| September 17, 2024 | 309.56M |
| September 16, 2024 | 323.95M |
| September 13, 2024 | 335.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.722M
Minimum
Nov 22 2019
3.066B
Maximum
May 03 2021
440.17M
Average
242.32M
Median
Oct 08 2024
Enterprise Value Benchmarks
| Cytokinetics Inc | 5.270B |
| Scholar Rock Holding Corp | 2.408B |
| Mirum Pharmaceuticals Inc | 2.110B |
| SpringWorks Therapeutics Inc | 2.324B |
| NeuroBo Pharmaceuticals Inc | -1.421M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.97M |
| Revenue (Quarterly) | 1.136M |
| Total Expenses (Quarterly) | 14.39M |
| EPS Diluted (Quarterly) | -0.05 |
| Profit Margin (Quarterly) | -1.14K% |
| Earnings Yield | -19.98% |
| Normalized Earnings Yield | -19.98 |